EXODIAB: Excellence of Diabetes Research in Sweden
1661 – 1670 of 4132
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Difference in the risk profiles of carotid-femoral pulse wave velocity : results from two community-based studies in China and Sweden
2019) In Journal of Human Hypertension(
- Contribution to journal › Article
-
Mark
Implementation of discharge recommendations in type 1 diabetes depends on specialist nurse follow-up
(
- Contribution to journal › Article
-
Mark
Birth weight and cardiac function assessed by echocardiography in adolescence : the Avon Longitudinal Study of Parents and Children
2019) In Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 54(2). p.225-231(
- Contribution to journal › Article
-
Mark
Pacing therapy in the management of unexplained syncope : A tertiary care centre prospective study
(
- Contribution to journal › Article
-
Mark
Preserving Insulin Secretion in Diabetes by Inhibiting VDAC1 Overexpression and Surface Translocation in β Cells
(
- Contribution to journal › Article
-
Mark
The calcium channel subunit gamma-4 is regulated by MafA and necessary for pancreatic beta-cell specification
(
- Contribution to journal › Article
-
Mark
Complement Component C3 Is Highly Expressed in Human Pancreatic Islets and Prevents β Cell Death via ATG16L1 Interaction and Autophagy Regulation
(
- Contribution to journal › Article
-
Mark
Lp-PLA
2
activity and mass and CRP are associated with incident symptomatic peripheral arterial disease
(
- Contribution to journal › Article
-
Mark
Intracellular cytosolic complement component C3 regulates cytoprotective autophagy in pancreatic beta cells by interaction with ATG16L1
(
- Contribution to journal › Debate/Note/Editorial